Avreo calls off Image Medical merger

Article

Despite announcing at the RSNA meeting that the deal was all but done, Avreo has opted not to acquire Image Medical and merge its PracticeBuilder image management product into Avreo's ARIIS radiology information workflow platform. Avreo (formerly Riptide

Despite announcing at the RSNA meeting that the deal was all but done, Avreo has opted not to acquire Image Medical and merge its PracticeBuilder image management product into Avreo's ARIIS radiology information workflow platform. Avreo (formerly Riptide Technologies) had planned to issue 3.9 million shares of common stock to purchase Image Medical as part of the company's vision of providing end-to-end radiology services. Avreo is now looking at other streaming and compression technologies that should give its customers the same benefits the company had expected to offer via PracticeBuilder.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.